Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
1.
J Pharm Sci ; 111(2): 469-478, 2022 02.
Article in English | MEDLINE | ID: mdl-34534573

ABSTRACT

Nanoparticles (NPs) that can activate macrophages infected with the tuberculosis causative pathogen Mycobacterium tuberculosis, could be an effective host directed therapy for the disease. In this study, curdlan was conjugated to poly(lactic-co-glycolic acid) (PLGA) to produce immunotherapeutic NPs. Various physicochemical characterizations were used to evaluate the curdlan-PLGA copolymer and the NPs. Molecular dynamics and simulation studies were used to characterize the interaction between curdlan, on the polymer and on NPs, with the Dectin-1 macrophage receptor. NPs with varying curdlan densities were evaluated for their effects on the production of pro- and anti-inflammatory cytokines in M. tuberculosis infected RAW264.7 macrophages. The killing efficacy of the NPs against intracellular M. tuberculosis was assessed. Physicochemical characterization of the curdlan-PLGA copolymer and NPs indicated successful formation of curdlan-PLGA copolymer and NPs of varying curdlan density (0-8% w/w) had sizes between 330 and 453 nm. Modelling studies showed curdlan to have a strong affinity for Dectin-1. Cytotoxicity assays showed the NPs to be non-toxic over 72 h. The proinflammatory cytokine TNF-α was found to be significantly upregulated by the NPs. The NPs reduced intracellular M. tuberculosis burden over 72 h. These NPs are a promising host directed therapy for intracellular eradication of M. tuberculosis.


Subject(s)
Mycobacterium tuberculosis , Nanoparticles , Drug Carriers/chemistry , Glycols , Lactic Acid/chemistry , Nanoparticles/chemistry , Polyglycolic Acid/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , beta-Glucans
2.
Parasitology ; 145(4): 443-452, 2018 04.
Article in English | MEDLINE | ID: mdl-29113609

ABSTRACT

The visceralizing potential of apparently dermotropic Leishmania donovani in Sri Lanka (L. donovani-SL) was investigated through long-term follow-up of cutaneous leishmaniasis (CL) patients and in vivo and in vitro experimental infection models. CL patients (n = 250) treated effectively with intra-lesional antimony therapy were followed-up six monthly for 4 years. There was no clinical evidence of visceralization of infection (VL) during this period. Infection of BALB/c mice with L. donovani-SL (test) through intra-dermal route led to the development of cutaneous lesions at the site of inoculation with no signs of systemic dissemination, in contrast to the observations made in animals similarly infected with a visceralizing strain of L. donovani-1S (control). Cytokine (IL-10, IFN-γ) release patterns of splenocytes and lymph node cell cultures derived from mice primed with experimental infections (with either test or control parasites) revealed significantly high IFN-γ response associated with test mice with CL, while prominent IL-10 levels were observed in association with control mice with VL. Furthermore, diminished infection efficiency, intracellular growth and survival of L. donovani-SL parasites compared with L. donovani-1S were evident through in vitro macrophage infection experiments. These studies confirm, for the first time, the essential dermotropic nature of L. donovani-SL suggesting natural attenuation of virulence of local parasite strains.


Subject(s)
Leishmania donovani/immunology , Leishmania donovani/pathogenicity , Leishmaniasis, Cutaneous/parasitology , Leishmaniasis, Visceral/parasitology , Skin/parasitology , Adolescent , Adult , Aged , Animals , Antimony/therapeutic use , Child , Child, Preschool , Clinical Studies as Topic , Cytokines/immunology , Follow-Up Studies , Humans , Infant , Interferon-gamma/immunology , Interleukin-10/immunology , Leishmania donovani/physiology , Leishmaniasis, Cutaneous/complications , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Cutaneous/epidemiology , Leishmaniasis, Visceral/diagnosis , Lymph Nodes/cytology , Lymph Nodes/immunology , Macrophages/parasitology , Male , Mice , Mice, Inbred BALB C , Middle Aged , Skin/pathology , Spleen/cytology , Spleen/immunology , Sri Lanka/epidemiology , Virulence , Young Adult
3.
Photochem Photobiol Sci ; 16(12): 1762-1770, 2017 Dec 06.
Article in English | MEDLINE | ID: mdl-29087425

ABSTRACT

The insertion of suitable metals or high Z elements in tumour-avid tetrapyrrole compounds is a promising approach to obtain potential agents for multimodal cancer therapeutics and tumour imaging. Using chlorin p6, a chlorophyll derivative, we synthesized a novel iodinated chlorin p6-copper complex (ICp6-Cu) that can be applied to the photodynamic therapy and photon activation therapy of cancer. In the present study, we investigated the interaction of ICp6-Cu with human serum albumin (HSA) using UV-Vis absorption and fluorescence spectroscopy. The addition of HSA to ICp6-Cu at physiological pH led to a ∼7 nm red shift in its Soret and Q band absorption. The binding constant (Kb) and the number of binding sites (n) of ICp6-Cu obtained from the quenching of the intrinsic fluorescence of HSA were 2.9 × 106 M-1 and 1.2 respectively. The distance between the Trp-214 residue and ICp6-Cu computed from Förster non-radiative energy transfer (FRET) theory was 3.1 nm. The emission of the ICp6-Cu fluorescence when excited at the protein's Trp absorption (295 nm) further substantiated the FRET between the Trp residue and ICp6-Cu. Synchronous spectroscopy revealed that the quenching of protein Trp fluorescence was higher than that of Tyr with no significant shift in peak position. Results suggested that HSA acts as a carrier protein for ICp6-Cu with a high probability that the binding of ICp6-Cu occurred at subdomain IIA and the binding had no effect on the conformation of HSA.


Subject(s)
Coordination Complexes/metabolism , Copper/chemistry , Porphyrins/chemistry , Serum Albumin, Human/chemistry , Serum Albumin, Human/metabolism , Binding Sites , Coordination Complexes/chemistry , Fluorescence Resonance Energy Transfer , Humans , Kinetics , Protein Binding , Spectrophotometry , Tryptophan/chemistry , Tryptophan/metabolism
4.
Int J Obstet Anesth ; 31: 51-56, 2017 May.
Article in English | MEDLINE | ID: mdl-28684138

ABSTRACT

BACKGROUND: We developed a real-time 3D ultrasound thick slice rendering technique and innovative Epiguide needle-guide as an adjunct to single-operator midline epidural needle insertions. Study goals were to determine feasibility of the technique in a porcine model and compare the visibility of standard and echogenic needles. METHODS: Thirty-four lumbar needle insertions were performed on six intact porcine spines ex vivo. Ultrasound scanning identified the insertion site and, using an Epiguide, the needle was guided into the epidural space through the ligamentum flavum in the midline plane, watched in real-time on the 3D ultrasound. Entry into the epidural space was judged by a loss-of-resistance technique. Needle visibility was rated by the anesthesiologist performing the technique using a 4-point scale; (0=cannot see, 1=poor, 2=satisfactory, 3=excellent), and later by an independent assessor viewing screenshots. The procedure was repeated at all lumbar levels using either the standard or echogenic needle. RESULTS: Successful loss-of-resistance to fluid was achieved in 76% of needle insertions; needle visibility with echogenic needles (94.2% rated satisfactory/excellent) was significantly better than with standard needles (29.4% satisfactory/excellent, P<0.0001). Successful loss-of-resistance was 93% when mean needle visibility was rated as 'excellent'. Inter-observer agreement between assessors was 'near-perfect' (weighted kappa=0.83). CONCLUSION: It is feasible to perform 3D ultrasound-guided real-time single-operator midline epidural insertions, in a porcine model. Echogenic needles were found to consistently improve needle visibility; and improved needle visibility tended to increase successful entry into epidural space.


Subject(s)
Epidural Space/diagnostic imaging , Imaging, Three-Dimensional/methods , Ultrasonography, Interventional/methods , Anesthesia, Epidural/methods , Anesthesia, Obstetrical/methods , Animals , Feasibility Studies , Female , Lumbosacral Region/anatomy & histology , Lumbosacral Region/diagnostic imaging , Needles , Observer Variation , Swine
5.
Int J Obstet Anesth ; 27: 41-5, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27317550

ABSTRACT

BACKGROUND: Between 10-22% of the general population experience needle phobia. Needle phobic parturients are at increased risk of adverse outcomes. We assessed the efficacy of topical Ametop™ (tetracaine 4%) gel in reducing the pain associated with local anesthetic skin infiltration before neuraxial block in non-laboring women. METHODS: This was a prospective, randomized, double-blind, placebo-controlled study. Ametop™ or placebo was applied to the skin of the lower back at least 20min before neuraxial block using a standardized technique with 1% lidocaine skin infiltration. The primary outcome was numeric pain score (0-10) 30s after lidocaine infiltration. Groups were compared using Welch's t-test. RESULTS: Thirty-six subjects in each group were analyzed. There was a statistically significant difference in the mean (standard deviation) pain score between the Ametop™ and the placebo groups: 2.36±1.80 and 3.51±2.22, respectively (P=0.019). There were no significant adverse events. CONCLUSION: The mean numeric pain score in the Ametop™ group was 33% lower compared to the placebo group. Topical Ametop™ gel applied at least 20min before local anesthetic infiltration of the skin prior to neuraxial block in elective cesarean delivery may be a useful adjunct in needle phobic women.


Subject(s)
Anesthesia, Epidural , Anesthesia, Obstetrical , Anesthetics, Local/administration & dosage , Pain/prevention & control , Tetracaine/administration & dosage , Adult , Anesthetics, Local/adverse effects , Double-Blind Method , Female , Humans , Parturition , Pregnancy , Prospective Studies , Tetracaine/adverse effects
6.
Clin Exp Immunol ; 185(2): 165-79, 2016 08.
Article in English | MEDLINE | ID: mdl-26898994

ABSTRACT

It is well known that a patient in clinical remission of visceral leishmaniasis (VL) remains immune to reinfection, which provides a rationale for the feasibility of a vaccine against this deadly disease. In earlier studies, observation of significant cellular responses in treated Leishmania patients as well as in hamsters against leishmanial antigens from different fractions led to its further proteomic characterization, wherein S-adenosyl-L-homocysteine hydrolase (AdoHcy) was identified as a helper type 1 (Th1) stimulatory protein. The present study includes immunological characterization of this protein, its cellular responses [lymphoproliferation, nitric oxide (NO) production and cytokine responses] in treated Leishmania-infected hamsters and patients as well as prophylactic efficacy against Leishmania challenge in hamsters and the immune responses generated thereof. Significantly higher cellular responses were noticed against recombinant L. donovani S-adenosyl-L-homocysteine hydrolase (rLdAdoHcy) compared to soluble L. donovani antigen in treated samples. Moreover, stimulation of peripheral blood mononuclear cells with rLdAdoHcy up-regulated the levels of interferon (IFN)-γ, interleukin (IL)-12 and down-regulated IL-10. Furthermore, vaccination with rLdAdoHcy generated perceptible delayed-type hypersensitivity response and exerted considerably good prophylactic efficacy (∼70% inhibition) against L. donovani challenge. The efficacy was confirmed by the increased expression levels of inducible NO synthase and Th1-type cytokines, IFN-γ and IL-12 and down-regulation of IL-4, IL-10 and transforming growth factor (TGF)-ß. The results indicate the potentiality of rLdAdoHcy protein as a suitable vaccine candidate against VL.


Subject(s)
Adenosylhomocysteinase/immunology , Adenosylhomocysteinase/metabolism , Leishmaniasis Vaccines/immunology , Leishmaniasis, Visceral/immunology , Th1 Cells/enzymology , Adenosylhomocysteinase/administration & dosage , Adenosylhomocysteinase/genetics , Adolescent , Adult , Animals , Antigens, Protozoan/immunology , Child , Child, Preschool , Cricetinae , Cytokines/genetics , Female , Humans , Leishmania donovani/immunology , Leishmania donovani/isolation & purification , Leishmaniasis, Visceral/prevention & control , Leukocytes, Mononuclear/immunology , Lymphocyte Activation , Male , Nitric Oxide/biosynthesis , Proteomics , Protozoan Proteins/immunology , Th1 Cells/immunology , Vaccination , Vaccines, Synthetic/immunology , Young Adult
7.
Parasite Immunol ; 37(7): 368-75, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25824598

ABSTRACT

Isolation of the soluble exogenous antigens (SEAgs), its immune response study and proteome profiling is an essential prerequisite for understanding the molecular pathogenesis of Leishmania donovani. The immunostimulatory potential of L. donovani SEAgs, purified from culture of L. donovani clinical isolate, was evaluated for their ability to induce cellular responses in treated/cured hamsters. SEAgs induced significant proliferative responses in lymphocytes (SI 5.6 ± 2.3; P < 0.01) isolated from cured hamster. In addition, significant NO production in response to SEAgs was also noticed in macrophages of hamsters, mouse and human cell lines (J774A-1 and THP1). Western blot analyses with antibodies against proteophosphoglycan (PPG; surface-expressed and secreted molecule) of L. donovani revealed that PPG molecules are also present in L. donovani SEAgs. Mass spectrometry (MS)-based proteome analysis of 12 protein bands of SEAgs through MALDI-TOF/TOF endorsed the identification of some Th1-stimulatory immunogenic proteins. These immunogenic proteins may offer increased hope for the discovery of new promising vaccine candidates against visceral leishmaniasis (VL). The overall results suggest that immunostimulatory molecules are present in the SEAgs, which may be further exploited, for developing a subunit vaccine against VL a fatal human disease.


Subject(s)
Antigens, Protozoan/immunology , Leishmania donovani/immunology , Leishmaniasis, Visceral/immunology , Macrophages/immunology , Animals , Antibodies/immunology , Antigens, Protozoan/isolation & purification , Cell Line , Cell Proliferation , Cricetinae , Humans , Immunization , Lymphocyte Activation/immunology , Lymphocytes/immunology , Macrophage Activation/immunology , Male , Mice , Proteome/immunology
8.
Afr. j. disabil. (Online) ; 3(2): 1-12, 2015. ilus
Article in English | AIM (Africa) | ID: biblio-1256830

ABSTRACT

Background: The 'EquitAble' project carried out content analyses of policies and collected and analysed qualitative and quantitative data concerning access to health services in Sudan, Malawi, Namibia and South Africa. Our particular concern was to address the situation of people with disabilities; although not in isolation from other marginalised or vulnerable groups. Objectives: This article reports on the content, context, process and impact of project EquitAble, funded by the European Commission Seventh Research Framework Programme, which brought together researchers from Ireland, Norway, South Africa, Namibia, Sudan and Malawi. Method: After the 4-year project ended in February 2013, all members of the consortium were asked to anonymously complete a bespoke questionnaire designed by the coordinating team. The purpose of the questionnaire was to capture the views of those who collaborated on the research project in relation to issues of content, context, process and impact of the EquitAble project. Results: Our results indicated some of the successes and challenges encountered by our consortium. Conclusion: We identified contextual and process learning points, factors often not discussed in papers, which typically focus on the reporting of the 'content' of results


Subject(s)
Health Services Accessibility , Health Services for Persons with Disabilities , Vulnerable Populations
9.
Parasite Immunol ; 36(6): 253-65, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24830833

ABSTRACT

The immunoprophylactic and therapeutic potentials of root extracts of Withania somnifera chemotypes (NMITLI-118, NMITLI-101) and pure withanolide-withaferin A was investigated against Leishmania donovani infection in hamsters. The naive animals, fed orally with immunostimulatory doses of chemotypes 101R, 118R (10 and 3 mg/kg) and withaferin A (9 and 3 mg/kg) for five consecutive days and challenged with Leishmania parasites on day 6, were euthanized on days 30 and 45 p.c. for the assessment of parasite clearance, real-time analysis of mRNAs of Th1/Th2 cytokines (IFN-γ, IL-12, TNF-α, iNOS/IL-4, IL-10 and TGF-ß), NO production, reactive oxygen species (ROS) generation, lymphocyte transformation test and antibody responses. By day 45 p.c., there was a significant increase in the mRNA expression of iNOS, IFN-γ, IL-12 and TNF-α but decrease in IL-4, IL-10 and TGF-ß, an enhanced Leishmania-specific LTT response as well as ROS, NO and antileishmanial IgG2 levels in 101R-treated hamsters followed by 118R- and withaferin A-treated ones, respectively. When these chemotypes were given to L. donovani-infected hamsters at different doses, there was moderate therapeutic efficacy of chemotype 101R (~50%) at 30 mg/kg × 5 followed by the other two. The results established that the 101R is the most potential chemotype and can be evaluated for combination therapy along with available antileishmanials.


Subject(s)
Leishmania donovani , Leishmaniasis, Visceral/drug therapy , Plant Extracts/therapeutic use , Withania/chemistry , Withanolides/therapeutic use , Animals , Antibody Formation , Cricetinae , Cytokines/immunology , Immunoglobulin G/metabolism , Immunoglobulin G/therapeutic use , Leishmania donovani/growth & development , Leishmaniasis, Visceral/immunology , Leishmaniasis, Visceral/prevention & control , Male , Plant Extracts/administration & dosage , Plant Roots/chemistry , Th1 Cells/immunology
10.
Br J Pharmacol ; 171(17): 4038-50, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24837879

ABSTRACT

BACKGROUND AND PURPOSE: The aim of the present study was to evaluate the immunomodulatory and chemotherapeutic potential of alginate-(SA) coated nanocapsule (NCs) loaded with doxorubicin (SA-NCs-DOX) against visceral leishmaniasis in comparison with nano-emulsions containing doxorubicin (NE-DOX). EXPERIMENTAL APPROACH: NE-DOX was prepared using low-energy emulsification methods. Stepwise addition of protamine sulphate and SA in a layer-by-layer manner was used to form SA-NCs-DOX. SA-NCs-DOX, NE-DOX and Free DOX were compared for their cytotoxicity against Leishmania donovani-infected macrophages in vitro and generation of T-cell responses in infected hamsters in vivo. KEY RESULTS: Size and ζ potential of the NE-DOX and SA-NCs-DOX formulations were 310 ± 2.1 nm and (-)32.6 ± 2.1 mV, 342 ± 4.1 nm and (-)29.3 ± 1.2 mV respectively. SA-NCs-DOX was better (1.5 times) taken up by J774A.1 macrophages compared with NE-DOX. SA-NCs -DOX showed greater efficacy than NE-DOX against intramacrophagic amastigotes. SA-NCs-DOX treatment exhibited enhanced apoptotic efficiency than NE-DOX and free DOX as evident by cell cycle analysis, decrease in mitochondrial membrane potential, ROS and NO production. T-cell responses, when assessed through lymphoproliferative responses, NO production along with enhanced levels of iNOS, TNF-α, IFN-γ and IL-12 were found to be up-regulated after SA-NCs-DOX, compared with responses to NE-DOX in vivo. Parasitic burden was decreased in Leishmania-infected hamsters treated with SA-NCs-DOX, compared with NE-DOX. CONCLUSIONS AND IMPLICATIONS: Our results provide insights into the development of an alternative approach to improved management of leishmaniasis through a combination of chemotherapy with stimulation of the innate immune system.


Subject(s)
Alginates/pharmacology , Antiprotozoal Agents/pharmacology , Coated Materials, Biocompatible/pharmacology , Daunorubicin/pharmacology , Leishmania donovani/drug effects , Nanocapsules/chemistry , Th1 Cells/drug effects , Alginates/administration & dosage , Alginates/chemistry , Animals , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/chemistry , Cell Line , Coated Materials, Biocompatible/administration & dosage , Coated Materials, Biocompatible/chemistry , Cricetinae , Daunorubicin/administration & dosage , Daunorubicin/chemistry , Glucuronic Acid/administration & dosage , Glucuronic Acid/chemistry , Glucuronic Acid/pharmacology , Hexuronic Acids/administration & dosage , Hexuronic Acids/chemistry , Hexuronic Acids/pharmacology , Leishmania donovani/immunology , Macrophages/drug effects , Macrophages/immunology , Macrophages/parasitology , Male , Mice , Th1 Cells/immunology
11.
Afr J Disabil ; 3(2): 89, 2014.
Article in English | MEDLINE | ID: mdl-28730013

ABSTRACT

BACKGROUND: The 'EquitAble' project carried out content analyses of policies and collected and analysed qualitative and quantitative data concerning access to health services in Sudan, Malawi, Namibia and South Africa. Our particular concern was to address the situation of people with disabilities, although not in isolation from other marginalised or vulnerable groups. OBJECTIVES: This article reports on the content, context, process and impact of project EquitAble, funded by the European Commission Seventh Research Framework Programme, which brought together researchers from Ireland, Norway, South Africa, Namibia, Sudan and Malawi. METHOD: After the 4-year project ended in February 2013, all members of the consortium were asked to anonymously complete a bespoke questionnaire designed by the coordinating team. The purpose of the questionnaire was to capture the views of those who collaborated on the research project in relation to issues of content, context, process and impact of the EquitAble project. RESULTS: Our results indicated some of the successes and challenges encountered by our consortium. CONCLUSION: We identified contextual and process learning points, factors often not discussed in papers, which typically focus on the reporting of the 'content' of results.

12.
J Biosoc Sci ; 45(2): 145-66, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23168093

ABSTRACT

There is now widespread agreement on the importance of men's role in reproductive decision-making. Several studies have argued that fertility preferences and their translation into behaviour differ between polygamous and monogamous unions. Studies investigating the dominance of men's preferences over women's preferences, in cases of couple disagreement, found mixed evidence of the effect of polygamy. However, an often cited limitation of these studies has been the inability to link husband's intention with each of his wives in a polygamous union. By adding fertility-intention questions to an on-going Demographic Surveillance Site in Karonga District in northern Malawi the fertility preferences and contraceptive use of husbands and wives were investigated. An analysis of the relationship between the level of agreement and disagreement between husbands' and wives' fertility preferences was then performed to gain insight into the reproductive decision-making process of polygamous couples.


Subject(s)
Developing Countries , Family Characteristics , Marriage/psychology , Marriage/statistics & numerical data , Adolescent , Adult , Birth Rate , Choice Behavior , Contraception Behavior , Female , Humans , Malawi , Male , Middle Aged , Population Surveillance , Sex Factors , Socioeconomic Factors , Young Adult
13.
J Phys Chem B ; 116(14): 4199-205, 2012 Apr 12.
Article in English | MEDLINE | ID: mdl-22414064

ABSTRACT

We have investigated the diffusion of the photosensitizer Chlorin-p(6) (Cp(6)) across a egg lecithin lipid bilayer at different pH by the Second Harmonic Generation (SHG) method. Cp(6) has three ionizable carboxylic acid groups, and consequently, neutral and several ionic forms of Cp(6) are expected to be present in the pH range 3-8. The absorption spectra of Cp(6) get considerably modified in the presence of liposomes as the pH is decreased indicating that the drug liposome binding is pH dependent. The first pK(a) of interconversion (D-C) has been identified at pH ~7.0 by fluorescence measurement in an earlier work. In this work, the second pK(a) of interconversion (C-B) has been identified at pH ~4.8 by the hyper-Rayleigh scattering method. At acidic pH (3, 4, and 5), where species A, B, and C are dominant, the addition of liposomes to a Cp(6) solution generates an instantaneous rise (less than 1 s) in the second harmonic (SH) signal followed by decays whose time constants ranged from ten to hundreds of seconds. The instantaneous rise is attributed to the adsorption of Cp(6) to the outer lipid bilayer, and the decay is attributed to the diffusion of the neutral and charged (A and B) species of the drug. The observed fast and slow time constants for diffusion in the pH range 3-5 are attributed to the neutral (A) and ionic form (B) of Cp(6), respectively. At pH 6, the intensity of the generated SH signals on the addition of liposome reduced, and at physiological pH, it was too weak to be detected. These results are consistent with previous studies that show that the interaction between Cp(6) and egg-PC liposomes is pH dependent. At lower pH due to the presence of the hydrophobic species (A and B) of Cp(6), its interaction with liposomes is strong, and at higher pH, the abundance of the negatively charged hydrophilic species (C and D) decreases the interaction with the like charged liposomes. We have also studied the effect of increasing the bilayer rigidity by decreasing the temperature of the medium or by incorporating 50 mol % cholesterol in the lipid bilayer and observed that lowering of temperature has more profound effect on the diffusion rates. The characteristics of the SH signal changed significantly when liposomes incorporating 50 mol % cholesterol were used at a low (3 °C) temperature. Under these conditions, the SH signal consisted of an instantaneous (<1s) followed by a slower rise (10-90s), and then, it decayed on a much longer time scale. This slow rise of the SH signal at pH 3 and 4 may be attributed to the temperature dependent adsorption of the anionic species (B) of Cp(6) with the liposomes. Further investigations are required in order to understand clearly the pH dependent diffusion of this drug across lipid bilayers.


Subject(s)
Lipid Bilayers/chemistry , Phosphatidylcholines/chemistry , Porphyrins/chemistry , Cholesterol/chemistry , Diffusion , Hydrogen-Ion Concentration , Hydrophobic and Hydrophilic Interactions , Temperature
14.
J Assoc Physicians India ; 59: 91-4, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21751643

ABSTRACT

BACKGROUND: The prevalence of dementia is projected to rise dramatically in future with increasing life expectancy. Though dementia itself is not treatable in majority of cases, modification of co-morbid medical conditions may influence onset and rate of decline of cognitive functions. OBJECTIVE: To determine the prevalence of dementia in elderly by assessing cognitive function and to assess the association of cardiovascular risk factors with cognitive functions. STUDY DESIGN: Cross sectional analytical study. PARTICIPANTS: 400 consecutive elderly subjects > 65 years attending Geriatric OPD, Dept. of Medicine, Indira Gandhi Government Medical College, Nagpur, were recruited and assessed for cognitive functions by applying Mini Mental Status examination Score (MMSE). Relationships between cardiovascular risk factors and impaired cognitive score were determined. RESULTS: Prevalence of impaired cognitive function (MMSE Score < 25) was 33.25% (133 cases), while that of dementia (MMSE < 23) was 3.25 % (13 cases) in this elderly population. Impaired cognitive function was higher in those with low education and low socioeconomic status, (p = < 0.001). Increasing age, Female gender, alcohol intake and high cholesterol were found to be independently associated with impaired cognitive score in multiple logistic regression (p = < 0.001). Hypertension, diabetes mellitus, smoking and obesity were not associated with impaired cognitive score. CONCLUSION: Prevalence of cognitive impairment rises significantly as the age advances and is associated with alcohol intake and high cholesterol.


Subject(s)
Cardiovascular Diseases/complications , Cognition Disorders/complications , Cognition , Dementia/epidemiology , Age Distribution , Aged , Aged, 80 and over , Asian People , Cardiovascular Diseases/epidemiology , Cognition Disorders/diagnosis , Cognition Disorders/epidemiology , Cross-Sectional Studies , Dementia/complications , Dementia/diagnosis , Female , Humans , India/epidemiology , Logistic Models , Male , Neurologic Examination , Population Surveillance , Prevalence , Risk Factors , Sex Distribution , Socioeconomic Factors , Tomography, X-Ray Computed
15.
J Biomed Nanotechnol ; 7(1): 123-4, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21485834

ABSTRACT

The present study was aimed to assess the improvement of existing treatment regimens of Amphotericin B nanoconstrcuts which synergises with alginate for immunostimulation against visceral leishmaniasis. The particle size of Lip-nano (Plain AmB nanoconstructs) and Alg-Lip-nano (alginate capped Lip-nano) was 108.3 +/- 4.3 and 134.2 +/- 5.1 while zeta potential was (+) 28.4 +/- 3.3 and (-) 19.8 +/- 2.1 respectively. Percentage of parasite inhibition (intramacrophagic amastigotes) at 0.1 microg/ml conc. of AmB in case of Alg-Lip-nano (58%) was significantly higher (P = 0.05) compared to Lip-nano (48%). This supports that alginate coating over particles can activate macrophages to synergistically act with AmB in effective killing of parasite. This observation generates interest that immunotherapy with chemotherapeutic activity of AmB can effectively increase cure rate in visceral leishmaniasis.


Subject(s)
Alginates/chemistry , Amphotericin B/administration & dosage , Leishmania/drug effects , Leishmania/physiology , Lipids/chemistry , Nanocapsules/chemistry , Amphotericin B/chemistry , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/chemistry , Cell Survival/drug effects , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Nanocapsules/administration & dosage , Treatment Outcome
16.
J Biomed Nanotechnol ; 6(3): 293-302, 2010 Jun.
Article in English | MEDLINE | ID: mdl-21179947

ABSTRACT

The present study was aimed to assess the efficacy of developed transfersome (TF-3) formulation bearing amphotericin B (AmB) against sensitive and resistant clinical isolates of L donovani and compared with conventional liposomal formulation (F-2) and free AmB (F-1). The skin permeation of AmB from TF-3 was performed using Franz diffusion cell using rat skin which showed fickian diffusion across the skin. When tested against L. donovani (intramacrophagic amastigotes), it has been observed that TF was more effective than F-1 and F-2 formulation in sensitive and resistant clinical isolates. The data provides evidences that the TF formulation owing to its fluidized behaviour imparted by sodium deoxycholate, enables to penetrate well in the infected cells and thus provide enhanced activity. The permeation study also supports this data as the flux value of AmB through TF formulation was 1.5 fold higher compared to conventional liposomes suggesting improved penetration and better partitioning in skin layers. Implicit to this preliminary data it is evident that the AmB loaded TF formulation has potential as alternate chemotherapeutic approach to control of VL. Potential utilities of novel formulation as a transdermal delivery of AmB for leishmaniasis necessitates further elaborated investigations which is underway in our laboratory.


Subject(s)
Amphotericin B/administration & dosage , Amphotericin B/chemistry , Leishmaniasis, Visceral/drug therapy , Liposomes/chemical synthesis , Skin Absorption , Animals , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/chemistry , Drug Compounding , Drug Resistance , Mice , Rats , Treatment Outcome
17.
Skin Pharmacol Physiol ; 23(2): 79-85, 2010.
Article in English | MEDLINE | ID: mdl-20016249

ABSTRACT

We report the results of a study carried out to investigate the effect of helium-neon (He-Ne) laser (632.8 nm) irradiation on the hair follicle growth cycle of testosterone-treated and untreated mice. Both histology and optical coherence tomography (OCT) were used for the measurement of hair follicle length and the relative percentage of hair follicles in different growth phases. A positive correlation (R = 0.96) was observed for the lengths of hair follicles measured by both methods. Further, the ratios of the lengths of hair follicles in the anagen and catagen phases obtained by both methods were nearly the same. However, the length of the hair follicles measured by both methods differed by a factor of 1.6, with histology showing smaller lengths. He-Ne laser irradiation (at approximately 1 J/cm(2)) of the skin of both the control and the testosterone-treated mice was observed to lead to a significant increase (p < 0.05) in % anagen, indicating stimulation of hair growth. The study also demonstrates that OCT can be used to monitor the hair follicle growth cycle, and thus hair follicle disorders or treatment efficacy during alopecia.


Subject(s)
Hair Follicle/radiation effects , Hair/radiation effects , Lasers, Gas , Low-Level Light Therapy/methods , Alopecia/etiology , Alopecia/radiotherapy , Animals , Hair/growth & development , Hair Follicle/growth & development , Male , Mice , Testosterone/administration & dosage , Testosterone/metabolism , Tomography, Optical Coherence
18.
Indian J Med Res ; 129(4): 438-41, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19535840

ABSTRACT

BACKGROUND & OBJECTIVE: In India a chikungunya fever outbreak started in December 2005 when the country experienced more than 13 lakhs of chikungunya infected cases. We undertook this study to study detailed clinical profile of chikungunya fever in both indoor and outdoor patients in a tertiary care hospital in Nagpur, Maharashtra in 2006. METHODS: Suspected cases of chikungunya fever (n=405) during the period of July to September 2006, having clinical triad of fever, arthralgia and/or rashes were included in the study. Clinical profile was studied in all the cases. Of the 405 samples collected, 166 were tested for serum CHIK IgM antibodies. RESULTS: Of the 166 samples tested for CHIKV IgM antibodies, 87 (52.4%) were positive (confirmed cases). Male: female ratio was 2.3:1. Fever and arthralgia were present in all cases. Rash was present in 27 (31%) confirmed and 38 (12%) suspected cases. Lymphadenopathy was present in 12 (13.8 %) confirmed and 4 of suspected cases. Chronic polyarthritis was seen in 22 (25.3%) confirmed and 75 (23.6%) suspected cases. Neurological manifestations were observed in 08 (9%) confirmed and 10 (3.14%) suspected cases. Mortality was 7 (2.2%) in 318 suspected cases and 3 (3.4%) in 87 confirmed cases. INTERPRETATION & CONCLUSION: Our findings showed that about half of the serum samples for CHIKV IgM antibody tested positive from cases suspected to have chikungunya fever. Fever, joint pain and headache were major symptoms. Certain rare manifestations like lymphodenopathy, oral ulcers and encephalitis were also seen. Mortality in confirmed cases was about 3.4 per cent.


Subject(s)
Alphavirus Infections/epidemiology , Alphavirus Infections/pathology , Chikungunya virus/genetics , Disease Outbreaks , Adolescent , Adult , Alphavirus Infections/mortality , Female , Humans , Immunoglobulin M/blood , India/epidemiology , Male , Reverse Transcriptase Polymerase Chain Reaction
19.
Scand J Immunol ; 68(5): 492-501, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18803606

ABSTRACT

T-cell mediated immune responses are key determinants to the natural course of infection caused by intracellular parasites such as Leishmania. Thus, T-cell activating proteins of these microbes continue to generate active interest particularly in view of their possible role in the design and development of newer and more effective vaccines. We have recently reported the presence of T-cell immunostimulatory antigens with the high-molecular-weight (MW) fractions (134-64.2 kDa) of whole Leishmania donovani antigen (strain 2001), which stimulated variable amounts of IFN-gamma, IL-12 and IL-10 in exposed immune individuals. The present study was undertaken to further evaluate these high-MW antigenic fractions (MW range >100-60 kDa) for potential protective efficacy. The high-MW region of the parasite was resolved into five antigenic fractions (Prep A-E) using continuous elution gel electrophoresis. Prior to in vivo protection studies in hamsters, these fractions were used to evaluate in vitro cellular responses in eight Leishmania-exposed individuals and treated cured hamsters. The protective efficacy of prep (A + B), C, D and E in combination with BCG was evaluated in inbred hamsters using standard immunization protocol. Proliferative responses were seen in all eight of eight exposed individuals to prep D [median stimulation index (SI): 5.2 (range 3.9-7.1)] and E [median SI: 5.6 (range 4.4-8.2)], five of eight individuals to prep B and prep C and three of eight to prep A [median SI: 0.2 (range 0.1-7.2)]. The median proliferative responses to prep D and prep E were significantly higher than to fraction prep A; (P < 0.05) but not to prep B and prep C. However, prep A-E induced equivalent levels of IFN-gamma, IL-10 and IL-12 cytokines. Fractions D and E also exhibited marked parasite inhibition in spleen (52.5% and 73.7%) and liver (65% and 80.2%) as compared with prep (A + B) (23% in spleen and 24% in liver) and prep C (38% in spleen and 24% in liver). Prep D and prep E vaccinated animals showed higher in vitro stimulatory responses (mean SI: 6.6 and 8.8) and nitric oxide (NO) induction (mean NO levels: 6.4 and 10.7 mug/ml) against whole cell extract as compared with other groups. The protection also correlated with presence of suppressed Leishmania-specific IgG levels in prep D and prep E immunized hamsters. These studies indicate the presence of immunostimulatory and protective molecules in 60-80 kDa region of L. donovani, which may be further exploited for developing a subunit vaccine.


Subject(s)
Antigens, Protozoan/pharmacology , Leishmania donovani/immunology , Leishmaniasis, Visceral/immunology , T-Lymphocytes/immunology , Adult , Animals , Antibodies, Protozoan/blood , Antigens, Protozoan/isolation & purification , Cell Proliferation , Cricetinae , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunization , Interferon-gamma/immunology , Interleukin-10/immunology , Interleukin-12/immunology , Leishmania donovani/isolation & purification , Leishmaniasis, Visceral/parasitology , Leishmaniasis, Visceral/prevention & control , Liver/immunology , Liver/parasitology , Lymphocyte Activation , Male , Mesocricetus , Spleen/immunology , Spleen/parasitology
20.
Parasitology ; 134(Pt 9): 1175-84, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17362540

ABSTRACT

Leishmania produce several types of mucin-like glycoproteins called proteophosphoglycans (PPGs) some of which are secreted while others are found on the surface of promastigotes and amastigotes. These proteins are thought to be important in the transmission, invasion and subsequent intracellular survival of parasites. The structure and function of PPGs are species and stage-specific in the case of L. major and L. mexicana, but no such information has hitherto been available for L. donovani. This study presents, for the first time, an initial characterization (localization) of PPG in sodium stibogluconate (SSG)-resistant and sensitive clinical isolates of L. donovani from Bihar (India) by confocal microscopy, flow cytometry and Western blotting using antibodies to L. major PPG. Confocal microscopy analysis revealed that both promastigotes and amastigotes possess PPG on their cell membrane and flagellar pocket membrane but its expression was variable in different isolates. The quantitative analysis by FACS and Western blotting showed that the expression and intensity of PPG bands was higher in SSG-resistant isolates. This study suggests the possibilities of involvement of PPG in drug-resistant mechanisms and of using PPG abundance as a marker for identifying drug-resistant clinical isolates in Indian kala azar.


Subject(s)
Antimony Sodium Gluconate/pharmacology , Drug Resistance/genetics , Leishmania donovani/drug effects , Leishmania donovani/genetics , Membrane Proteins/genetics , Proteoglycans/genetics , Protozoan Proteins/genetics , Animals , Antiprotozoal Agents/pharmacology , Cell Line , Cricetinae , India/epidemiology , Leishmania donovani/cytology , Leishmania donovani/metabolism , Leishmaniasis, Visceral/epidemiology , Leishmaniasis, Visceral/parasitology , Macrophages/parasitology , Male , Membrane Proteins/metabolism , Mesocricetus , Mice , Proteoglycans/metabolism , Protozoan Proteins/metabolism , Spleen/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...